These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14610380)

  • 1. Challenges and controversies in the prevention and treatment of cardiovascular disease in very elderly patients.
    Kitzman DW
    Am J Geriatr Cardiol; 2003; 12(6):343. PubMed ID: 14610380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and treatment in the elderly. 2002 recommendations of the National Heart-Circulation Conference].
    Held K;
    Dtsch Med Wochenschr; 2002 May; 127(19):1039-41. PubMed ID: 11997875
    [No Abstract]   [Full Text] [Related]  

  • 3. Socioeconomic status and health inequalities for cardiovascular prevention among elderly Spaniards.
    Mejía-Lancheros C; Estruch R; Martínez-González MA; Salas-Salvadó J; Corella D; Gómez-Gracia E; Fiol M; Lapetra J; Covas MI; Arós F; Serra-Majem L; Pintó X; Basora J; Sorlí JV; Muñoz MA;
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):803-11. PubMed ID: 24773861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing profile of the cardiovascular patient and the future of cardiovascular disease treatment and prevention: British Columbia as an example.
    Ignaszewski AP; Ignaszewski MJ
    Kardiol Pol; 2011; 69(10):1099-103. PubMed ID: 22006622
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular risk factors and dementia--towards prevention strategies.
    Richard E; Ligthart SA; Moll van Charante EP; van Gool WA
    Neth J Med; 2010 Oct; 68(10):284-90. PubMed ID: 21071773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol: until which age 'the lower the better'?
    Marchionni N; Orso F
    Monaldi Arch Chest Dis; 2016 Jun; 84(1-2):749. PubMed ID: 27374051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eating habits in the prevention of cardiovascular diseases and associated factors in elderly hypertensive individuals].
    Gadenz SD; Benvegnú LA
    Cien Saude Colet; 2013 Dec; 18(12):3523-33. PubMed ID: 24263869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic Strategies. Cardiovascular risk and dyslipidemia in elderly and women].
    Morales C; Royuela M
    Clin Investig Arterioscler; 2013; 25(3):146-50. PubMed ID: 23786854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cardiovascular complications in elderly cancer patients.
    Topa E; Rizza M; Iengo M; Cuomo A; Cicia L; Di Sarro E; Miccio M; Ciaccio G; Luise MC; Formisano L; Bianco R; Carlomagno C; Picardi M; Martinelli E; Napolitano S; Troiani T; Ferrara N; Abete P; Tocchetti CG; Mercurio V
    Vascul Pharmacol; 2024 Jun; 155():107354. PubMed ID: 38985632
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular disease in the elderly.
    Alam S; Abou-Khamis A
    J Med Liban; 1997; 45(3):148-54. PubMed ID: 9396200
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of cardiovascular disease among the elderly.
    Karvonen MJ
    Bull World Health Organ; 1988; 66(1):7-14. PubMed ID: 3260144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular prevention in the over-80 age group is beneficial].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):26. PubMed ID: 18240757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise prescription and primary prevention of cardiovascular disease.
    Metkus TS; Baughman KL; Thompson PD
    Circulation; 2010 Jun; 121(23):2601-4. PubMed ID: 20547940
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular research in the elderly: challenges, opportunities, and impact.
    Califf RM; Alexander KP
    Postgrad Med; 2002 Dec; 112(6 Suppl Heart):6-11. PubMed ID: 19667612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease?' No, but we can improve risk communication metrics.
    Jackson R; Kerr A; Wells S
    Eur Heart J; 2017 May; 38(20):1548-1552. PubMed ID: 27436864
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypercholesterolemia, cardiovascular risk, and hypocholesteremic treatment in the elderly].
    Cicconetti P; Ciotti V; Tafaro L; Riolo N; Marigliano V
    Recenti Prog Med; 2002 Apr; 93(4):264-72. PubMed ID: 11989134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of vascular risk factors in patients older than 80].
    Gómez-Huelgas R; Martínez-Sellés M; Formiga F; Alemán Sánchez JJ; Camafort M; Galve E; Gil P; Lobos JM
    Med Clin (Barc); 2014 Aug; 143(3):134.e1-11. PubMed ID: 24908624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benefits of hypertension treatment in the elderly].
    Girerd X; Hanon O
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):518-22. PubMed ID: 12555376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic hypertension in the elderly: potential for primary prevention of cardiovascular disease.
    Rich MW
    Aging (Milano); 1998 Apr; 10(2):169. PubMed ID: 9666225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.